![G. Cole](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
G. Cole
Direktor/Vorstandsmitglied bei
CASTLE BIOSCIENCES, INC.
Vermögen: 1 Mio $ am 31.05.2026
Profil
G.
Bradley Cole currently works at Castle Biosciences, Inc., as Independent Director from 2018, Kiniksa Pharmaceuticals Ltd., as Independent Director from 2020, Genomic Life, Inc., as Chief Financial Officer & Director, Kiniksa Pharmaceuticals International Plc, as Independent Director from 2024, Biola University, Inc. (California), as Trustee, and Applied Biosciences, Inc., as Chief Financial Officer from 2020.
Mr. Cole also formerly worked at Guidant Corp., as Vice President-Finance & Business Development from 1997 to 2004, EndoVascular Technologies, Inc., as Chief Financial Officer & Vice President-Finance from 1994 to 1997, EXACT Sciences Corp., as General Manager-Precision Oncology from 2019 to 2020, Genomic Health, Inc., as Chief Operating Officer from 2013 to 2014, and Applied Biosystems, Inc., as Chief Financial Officer & Vice President-Finance from 1988 to 1994.
Mr. Cole received his undergraduate degree from Biola University, Inc. (California) and Masters Business Admin degree from San Jose State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0.03% | 29.05.2026 | 15’345 ( 0.03% ) | 742 391 $ | 31.05.2026 |
| 28.05.2026 | 32’976 ( 0.11% ) | 695 134 $ | 31.05.2026 |
Aktive Positionen von G. Cole
| Unternehmen | Position | Beginn |
|---|---|---|
| CASTLE BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 06.12.2018 |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Direktor/Vorstandsmitglied | 27.07.2020 |
Genomic Life, Inc.
 Genomic Life, Inc. Medical/Nursing ServicesHealth Services Provides health and genomic medicines | Finanzdirektor/CFO | - |
Biola University, Inc. (California)
 Biola University, Inc. (California) Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
Applied Biosciences, Inc. | Finanzdirektor/CFO | 01.07.2020 |
Ehemalige bekannte Positionen von G. Cole
| Unternehmen | Position | Ende |
|---|---|---|
| EXACT SCIENCES CORPORATION | Corporate Officer/Principal | 01.04.2020 |
Guidant Corp.
 Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Finanzdirektor/CFO | 01.05.2004 |
EndoVascular Technologies, Inc.
 EndoVascular Technologies, Inc. Medical SpecialtiesHealth Technology Makes invasive endovascular systems | Finanzdirektor/CFO | 01.12.1997 |
Applied Biosystems, Inc.
 Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Manufactures genomics and proteomics related research instruments | Finanzdirektor/CFO | 01.02.1994 |
| ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von G. Cole
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
63
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Health Technology |
EndoVascular Technologies, Inc.
EndoVascular Technologies, Inc. Medical SpecialtiesHealth Technology Makes invasive endovascular systems | Health Technology |
EXACT Sciences Corp.
 EXACT Sciences Corp. Medical SpecialtiesHealth Technology Develops proprietary technologies for the detection of cancer | Health Technology |
Genomic Health, Inc.
 Genomic Health, Inc. Medical/Nursing ServicesHealth Services Engages in genomic-based diagnostic tests for overtreatment and optimal treatment of early stage cancer | Health Services |
Castle Biosciences, Inc.
 Castle Biosciences, Inc. Medical SpecialtiesHealth Technology Operates dermatological cancer company which provides clinically actionable genomic information to make accurate treatment decisions | Health Technology |
Biola University, Inc. (California)
Biola University, Inc. (California) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Jose State University
 San Jose State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Applied Biosciences, Inc. | |
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Manufactures genomics and proteomics related research instruments | Health Technology |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Genomic Life, Inc.
Genomic Life, Inc. Medical/Nursing ServicesHealth Services Provides health and genomic medicines | Health Services |
